Description

Oxaliplatin Amaxa Concentrate for Infusions 5 mg/ml. 10 ml. №1

Ingredients:

Each ml contains 5 mg of oxaliplatin. Other ingredients include lactose monohydrate, water for injections, and hydrochloric acid for pH adjustment.

Dosage:

The dosage of Oxaliplatin Amaxa concentrate is individualized based on the patient’s body surface area and health condition. It is administered intravenously over a specific period as directed by a healthcare professional.

Indications:

Oxaliplatin Amaxa concentrate is indicated for the treatment of colorectal cancer. It is used in combination with other chemotherapy medications to help slow or stop cancer cell growth.

Contraindications:

Do not use Oxaliplatin Amaxa concentrate if you are allergic to oxaliplatin or any of the ingredients. It is not recommended for patients with pre-existing kidney problems or bone marrow suppression.

Directions:

Oxaliplatin Amaxa concentrate should only be administered by healthcare professionals experienced in chemotherapy treatments. The infusion should be given slowly into a vein to minimize the risk of side effects.

Scientific Evidence:

Oxaliplatin, the active ingredient in Oxaliplatin Amaxa concentrate, is a platinum-based chemotherapy drug that works by interfering with the DNA in cancer cells, ultimately leading to cell death. Studies have shown that oxaliplatin, in combination with other chemotherapy agents, is effective in treating colorectal cancer.

Additional Information:

Patients receiving Oxaliplatin Amaxa concentrate may experience side effects such as nausea, fatigue, and peripheral neuropathy. It is important to discuss any concerns or symptoms with your healthcare provider.

Clinical trials have demonstrated the efficacy of Oxaliplatin Amaxa concentrate in improving progression-free survival and overall survival rates in patients with advanced colorectal cancer. Regular monitoring and follow-up are essential during treatment to assess the response and manage any adverse effects.